Jay C. Fournier, MA; Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Sona Dimidjian, PhD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; Jan Fawcett, MD (January 2010). "Antidepressant Drug Effects and Depression Severity". The Journal of the American Medical Association303 (1): 47–53. doi:10.1001/jama.2009.1943. PMID 20051569. Mm. "The magnitude of benefit of antidepressant medication compared with placebo ... may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial."
Jay C. Fournier, MA; Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Sona Dimidjian, PhD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; Jan Fawcett, MD (January 2010). "Antidepressant Drug Effects and Depression Severity". The Journal of the American Medical Association303 (1): 47–53. doi:10.1001/jama.2009.1943. PMID 20051569. Mm. "The magnitude of benefit of antidepressant medication compared with placebo ... may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial."
Peter C. Gøtzsche, Pernille K. Gøtzsche: Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. Journal of the Royal Society of Medicine, 2017-10, nro 10, s. 404–410. PubMed:29043894. doi:10.1177/0141076817731904. ISSN 1758-1095. Artikkelin verkkoversio.
Christopher Baethge, Oliver P. Assall, Ross J. Baldessarini: Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000–2010. Psychotherapy and Psychosomatics, 2013, nro 3, s. 152–160. PubMed:23548796. doi:10.1159/000346144. ISSN 1423-0348. Artikkelin verkkoversio.
Per-Henrik Zahl, Diego De Leo, Øivind Ekeberg, Heidi Hjelmeland, Gudrun Dieserud: The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry, 6.8.2010, nro 1, s. 62. PubMed:20691035. doi:10.1186/1471-244X-10-62. ISSN 1471-244X. Artikkelin verkkoversio.
Melanie P Jensen, Oliver J Ziff, Gargi Banerjee, Gareth Ambler, David J Werring: The impact of selective serotonin reuptake inhibitors on the risk of
intracranial haemorrhage: A systematic review and meta-analysis. European Stroke Journal, 2019-6, nro 2, s. 144–152. PubMed:31259262. doi:10.1177/2396987319827211. ISSN 2396-9873. Artikkelin verkkoversio.
Goldmeier D, Bell C, Richardson D (March 2006). "Withdrawal of selective serotonin reuptake inhibitors (SSRIs) may cause increased atrial natriuretic peptide (ANP) and persistent sexual arousal in women?". J Sex Med3 (2): 376. doi:10.1111/j.1743-6109.2006.00224.x. PMID 16490037.
Per-Henrik Zahl, Diego De Leo, Øivind Ekeberg, Heidi Hjelmeland, Gudrun Dieserud: The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry, 6.8.2010, nro 1, s. 62. PubMed:20691035. doi:10.1186/1471-244X-10-62. ISSN 1471-244X. Artikkelin verkkoversio.
Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R: Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. New England Journal of Medicine, 2008, 358. vsk, s. 252–260. Artikkelin verkkoversio. (englanniksi)
Heel RC, Morley PA, et al. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs. 1982 Sep;24(3):169–206. PMID 6215240
Fagius J, Osterman PO, et al. Guillain-Barré syndrome following zimeldine treatment. J Neurol Neurosurg Psychiatry. 1985 Jan;48(1):65–9. PMID 3156214
Jay C. Fournier, MA; Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Sona Dimidjian, PhD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; Jan Fawcett, MD (January 2010). "Antidepressant Drug Effects and Depression Severity". The Journal of the American Medical Association303 (1): 47–53. doi:10.1001/jama.2009.1943. PMID 20051569. Mm. "The magnitude of benefit of antidepressant medication compared with placebo ... may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial."
Peter C. Gøtzsche, Pernille K. Gøtzsche: Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. Journal of the Royal Society of Medicine, 2017-10, nro 10, s. 404–410. PubMed:29043894. doi:10.1177/0141076817731904. ISSN 1758-1095. Artikkelin verkkoversio.
J. G. Rabkin, J. S. Markowitz, J. Stewart, P. McGrath, W. Harrison, F. M. Quitkin: How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Research, 1986–9, nro 1, s. 75–86. PubMed:3538107. ISSN 0165-1781. Artikkelin verkkoversio.
Christopher Baethge, Oliver P. Assall, Ross J. Baldessarini: Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000–2010. Psychotherapy and Psychosomatics, 2013, nro 3, s. 152–160. PubMed:23548796. doi:10.1159/000346144. ISSN 1423-0348. Artikkelin verkkoversio.
Melanie P Jensen, Oliver J Ziff, Gargi Banerjee, Gareth Ambler, David J Werring: The impact of selective serotonin reuptake inhibitors on the risk of
intracranial haemorrhage: A systematic review and meta-analysis. European Stroke Journal, 2019-6, nro 2, s. 144–152. PubMed:31259262. doi:10.1177/2396987319827211. ISSN 2396-9873. Artikkelin verkkoversio.
Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E. "SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients." J Sex Marital Ther. 1997 Fall;23(3):176–94.http://www.ncbi.nlm.nih.gov/pubmed/9292833
Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. "Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction." J Clin Psychiatry. 2001;62 Suppl 3:10–21.http://www.ncbi.nlm.nih.gov/pubmed/11229449
Goldmeier D, Bell C, Richardson D (March 2006). "Withdrawal of selective serotonin reuptake inhibitors (SSRIs) may cause increased atrial natriuretic peptide (ANP) and persistent sexual arousal in women?". J Sex Med3 (2): 376. doi:10.1111/j.1743-6109.2006.00224.x. PMID 16490037.
Peter C. Gøtzsche, Pernille K. Gøtzsche: Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. Journal of the Royal Society of Medicine, 2017-10, nro 10, s. 404–410. PubMed:29043894. doi:10.1177/0141076817731904. ISSN 1758-1095. Artikkelin verkkoversio.
J. G. Rabkin, J. S. Markowitz, J. Stewart, P. McGrath, W. Harrison, F. M. Quitkin: How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Research, 1986–9, nro 1, s. 75–86. PubMed:3538107. ISSN 0165-1781. Artikkelin verkkoversio.
Christopher Baethge, Oliver P. Assall, Ross J. Baldessarini: Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000–2010. Psychotherapy and Psychosomatics, 2013, nro 3, s. 152–160. PubMed:23548796. doi:10.1159/000346144. ISSN 1423-0348. Artikkelin verkkoversio.
Per-Henrik Zahl, Diego De Leo, Øivind Ekeberg, Heidi Hjelmeland, Gudrun Dieserud: The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry, 6.8.2010, nro 1, s. 62. PubMed:20691035. doi:10.1186/1471-244X-10-62. ISSN 1471-244X. Artikkelin verkkoversio.
Melanie P Jensen, Oliver J Ziff, Gargi Banerjee, Gareth Ambler, David J Werring: The impact of selective serotonin reuptake inhibitors on the risk of
intracranial haemorrhage: A systematic review and meta-analysis. European Stroke Journal, 2019-6, nro 2, s. 144–152. PubMed:31259262. doi:10.1177/2396987319827211. ISSN 2396-9873. Artikkelin verkkoversio.
Peter C. Gøtzsche, Pernille K. Gøtzsche: Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. Journal of the Royal Society of Medicine, 2017-10, nro 10, s. 404–410. PubMed:29043894. doi:10.1177/0141076817731904. ISSN 1758-1095. Artikkelin verkkoversio.
J. G. Rabkin, J. S. Markowitz, J. Stewart, P. McGrath, W. Harrison, F. M. Quitkin: How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Research, 1986–9, nro 1, s. 75–86. PubMed:3538107. ISSN 0165-1781. Artikkelin verkkoversio.
Christopher Baethge, Oliver P. Assall, Ross J. Baldessarini: Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000–2010. Psychotherapy and Psychosomatics, 2013, nro 3, s. 152–160. PubMed:23548796. doi:10.1159/000346144. ISSN 1423-0348. Artikkelin verkkoversio.
Per-Henrik Zahl, Diego De Leo, Øivind Ekeberg, Heidi Hjelmeland, Gudrun Dieserud: The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry, 6.8.2010, nro 1, s. 62. PubMed:20691035. doi:10.1186/1471-244X-10-62. ISSN 1471-244X. Artikkelin verkkoversio.
Melanie P Jensen, Oliver J Ziff, Gargi Banerjee, Gareth Ambler, David J Werring: The impact of selective serotonin reuptake inhibitors on the risk of
intracranial haemorrhage: A systematic review and meta-analysis. European Stroke Journal, 2019-6, nro 2, s. 144–152. PubMed:31259262. doi:10.1177/2396987319827211. ISSN 2396-9873. Artikkelin verkkoversio.
